A obesidade afeta a resposta ao tratamento com secukinumabe e sua persistência na espondilite anquilosante? Dados reais do registro TURKBIO
Mod Rheumatol.2023 doi 10.1093/mr/road061 Epub ahead of print
This observational study suggested that obesity did not affect secukinumab treatment response and drug retention in AS patients.